Phaos Technology Holdings (Cayman) Limited (POAS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Phaos Technology Holdings (Cayman) Limited stock (POAS) is currently trading at $1.56. Phaos Technology Holdings (Cayman) Limited PS ratio (Price-to-Sales) is 129.14. WallStSmart rates POAS as Sell.
- POAS PE ratio analysis and historical PE chart
- POAS PS ratio (Price-to-Sales) history and trend
- POAS intrinsic value — DCF, Graham Number, EPV models
- POAS stock price prediction 2025 2026 2027 2028 2029 2030
- POAS fair value vs current price
- POAS insider transactions and insider buying
- Is POAS undervalued or overvalued?
- Phaos Technology Holdings (Cayman) Limited financial analysis — revenue, earnings, cash flow
- POAS Piotroski F-Score and Altman Z-Score
- POAS analyst price target and Smart Rating
Phaos Technology Holdings (Cayman)
📊 No data available
Try selecting a different time range
Smart Analysis
Phaos Technology Holdings (Cayman) Limited (POAS) · 6 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Phaos Technology Holdings (Cayman) Limited (POAS) Key Strengths (0)
Phaos Technology Holdings (Cayman) Limited (POAS) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Revenue declining -93.10%, a shrinking business
Very expensive at 129.1x annual revenue
Very low institutional interest at 1.34%
Micro-cap company with very limited liquidity and high volatility
Supporting Valuation Data
Phaos Technology Holdings (Cayman) Limited (POAS) Detailed Analysis Report
Overall Assessment
This company scores 6/100 in our Smart Analysis, earning a F grade. Out of 6 metrics analyzed, 0 register as strengths (avg 0/10) while 6 fall into concern territory (avg 1.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
Limited fundamental strengths were identified. The bull case requires improvement in core metrics.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including Price/Sales (129.14) suggest expensive pricing. Growth concerns include Revenue Growth at -93.10%, which may limit upside. Profitability pressure is visible in Return on Equity at -1073.00%, Operating Margin at -1898.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -1073.00% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -93.10% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
POAS Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
POAS's Price-to-Sales ratio of 129.14x trades 29% below its historical average of 182.27x (27th percentile). The current valuation is 59% below its historical high of 316.31x set in Jan 2026, and 10% above its historical low of 116.88x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~300.8x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Phaos Technology Holdings (Cayman) Limited (POAS) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Phaos Technology Holdings (Cayman) Limited operates as a stable business with moderate growth and solid fundamentals. Revenue reached 167,710 with 93% decline year-over-year. The company is currently unprofitable, posting a 0.0% profit margin.
Key Findings
Spending 83% of revenue (139,720) on R&D, reinforcing its commitment to innovation and future growth.
Revenue contracted 93% YoY. Worth determining whether this is cyclical or structural.
Free cash flow is -4M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Phaos Technology Holdings (Cayman) Limited.
Bottom Line
Phaos Technology Holdings (Cayman) Limited offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Phaos Technology Holdings (Cayman) Limited(POAS)
NYSE MKT
HEALTHCARE
MEDICAL DEVICES
USA
Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. The company is headquartered in Singapore.